Synthetic approach generated two uranyl complexes, revealing distinct crystal structures and bonding features.
The reactions of UO2(NO3)2·6H2O or UO2(O2CMe)2·2H2O and 2,2′-{(1,2-ethanediyl)bis[nitrilo(phenyl)methylidene]}bisphenol (H2L) in MeOH and DMF have provided access to complexes [UO2(L)(MeOH)] (1) and [UO2(L)(DMF)]·DMF (2·DMF), respectively. The molecular structures of the complexes are similar. The central UVI atom is surrounded by five oxygen and two nitrogen atoms in a distorted pentagonal bipyramidal geometry; the two uranyl oxygen atoms are at the axial positions. Two phenolato oxygen and two imino nitrogen atoms from the tetradentate chelating (1.1111 using Harris notation) L2− ligand are located at the equatorial plane, which is completed by the oxygen atom of a terminally ligated solvent (MeOH, DMF) molecule. Interestingly, the L2− ligand adopts a chair (or stepped) conformation in 1 and a boat conformation in 2·DMF. The supramolecular features of 1 and 2·DMF are distinctly different due to the different H-bonding abilities of coordinated MeOH and DMF, and the presence of an extra-lattice solvent molecule in the latter. The solid complexes were studied by IR, Raman, electronic (UV/Vis), and emission spectroscopic techniques. Complex 1 decomposes in CHCl3 and DMSO, whereas the molecular structure of 2 is retained in these solvents. A new polymorph of the free ligand, H2L(B), has also been discovered and its crystal structure is described.
No takes yet. Share an insight, caveat, or question.
Skiadas et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: